Penserra Capital Management’s Clover Health Investments CLOV Stock Holding History

Penserra Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,854	Closed	-$38K	–	1021
2022 Q2	$38K	Buy	17,854 +2,424	+16%	+$6.44K	﹤0.01%	965
2022 Q1	$54K	Buy	15,430 +1,042	+7%	+$3.02K	﹤0.01%	980
2021 Q4	$53K	Buy	14,388 +302	+2%	+$1.85K	﹤0.01%	1011
2021 Q3	$104K	Sell	14,086 -12,008	-46%	-$103K	﹤0.01%	784
2021 Q2	$347K	Sell	26,094 -17,126	-40%	-$168K	0.01%	549
2021 Q1	$326K	Buy	43,220 +20,779	+93%	+$234K	0.01%	524
2020 Q4	$376K	Buy	+22,441	New	+$250K	0.01%	409

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Penserra Capital Management's CLOV Position: Q3 2022 in Review

Penserra Capital Management sold out of Clover Health Investments (CLOV) in Q3 2022, closing a stake of 17,854 shares — an estimated $38K sold.

Penserra Capital Management first reported a position in CLOV in Q4 2020 and held it in 7 quarters. The position peaked at $376K in Q4 2020. 175 funds tracked by Wall St. Rank hold CLOV as of Q3 2022.

Penserra Capital Management reported no remaining Clover Health Investments position as of Q3 2022 after selling out during the quarter.
Penserra Capital Management sold 17,854 Clover Health Investments shares in Q3 2022, an estimated $38K.
Penserra Capital Management first reported a position in Clover Health Investments in Q4 2020 and held it in 7 quarters.
Penserra Capital Management's Clover Health Investments position peaked at $376K in Q4 2020.
175 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.